Patton Fund Management Inc. bought a new position in Oracle Corporation (NYSE:ORCL - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 1,589 shares of the enterprise software provider's stock, valued at approximately $347,000.
Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in Oracle by 2.2% during the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider's stock valued at $22,498,982,000 after purchasing an additional 3,513,464 shares during the last quarter. Northern Trust Corp grew its holdings in shares of Oracle by 0.6% in the first quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider's stock worth $2,760,048,000 after purchasing an additional 120,889 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Oracle by 0.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 13,884,524 shares of the enterprise software provider's stock worth $1,941,195,000 after acquiring an additional 59,164 shares during the period. Amundi lifted its stake in Oracle by 3.3% in the first quarter. Amundi now owns 12,736,855 shares of the enterprise software provider's stock worth $1,749,280,000 after acquiring an additional 409,691 shares during the period. Finally, Polen Capital Management LLC lifted its position in Oracle by 17.6% during the first quarter. Polen Capital Management LLC now owns 12,609,101 shares of the enterprise software provider's stock valued at $1,762,878,000 after buying an additional 1,885,370 shares during the period. Institutional investors own 42.44% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently commented on ORCL shares. Cantor Fitzgerald lifted their price objective on Oracle from $271.00 to $400.00 and gave the stock an "overweight" rating in a report on Wednesday, September 10th. Rothschild & Co Redburn began coverage on Oracle in a report on Thursday. They set a "sell" rating and a $175.00 price target on the stock. JPMorgan Chase & Co. raised their price target on Oracle from $185.00 to $210.00 and gave the company a "neutral" rating in a research note on Monday, September 8th. Cowen reissued a "buy" rating and issued a $375.00 price target on shares of Oracle in a report on Wednesday, September 10th. Finally, Westpark Capital lifted their price target on Oracle from $195.00 to $246.00 and gave the stock a "buy" rating in a research note on Thursday, June 12th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $304.71.
View Our Latest Stock Analysis on ORCL
Insider Transactions at Oracle
In related news, Director Rona Alison Fairhead purchased 480 shares of the company's stock in a transaction dated Monday, July 7th. The shares were acquired at an average cost of $233.87 per share, for a total transaction of $112,257.60. Following the transaction, the director owned 22,110 shares of the company's stock, valued at $5,170,865.70. This trade represents a 2.22% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director William G. Parrett sold 11,500 shares of the business's stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $306.00, for a total value of $3,519,000.00. Following the transaction, the director owned 17,764 shares of the company's stock, valued at approximately $5,435,784. This represents a 39.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 112,092 shares of company stock valued at $32,960,165 over the last 90 days. Corporate insiders own 42.20% of the company's stock.
Oracle Price Performance
ORCL stock opened at $283.29 on Friday. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $345.72. The stock's fifty day simple moving average is $258.19 and its 200-day simple moving average is $200.44. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. The stock has a market capitalization of $805.03 billion, a price-to-earnings ratio of 65.58, a price-to-earnings-growth ratio of 3.13 and a beta of 1.46.
Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The firm had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. During the same quarter in the previous year, the business posted $1.39 EPS. Oracle's revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts expect that Oracle Corporation will post 5 EPS for the current year.
Oracle Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle's payout ratio is presently 46.30%.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report